Search alternatives:
significantly less » significantly lower (Expand Search), significantly reduce (Expand Search), significantly better (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), teer decrease (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
significantly less » significantly lower (Expand Search), significantly reduce (Expand Search), significantly better (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), teer decrease (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Pre-RT and post RT D-dimer levels in associated with prognostic significance.
Published 2025Subjects: -
8
-
9
-
10
-
11
-
12
Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation. Monocytes and NK cells purified from PBMC collected from 10 RZV recipients (demographics in S4 Table) before vaccination (D0) and 90 days post-vaccination (D90) were combined ex vivo and stimulated with VZV-rgE. A subset of D0 monocyte & NK cocultures was also treated with the TGFβ1 inhibitor LY (D0 LY), and a subset of D90 cocultures were supplemented with rhTGFβ1. The graph shows individual data points, means and p values calculated by Friedman test for repeated measures with FDR correction. LY treatment of cells collected on D0 significantly increased their activation to levels similar to D90. Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.
Published 2025“…Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.…”
-
13
-
14
-
15
-
16
<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation.
Published 2025“…Cells were overlayed 0.3% agarose, incubated for 4 days, and stained with crystal violets. <b>(B)</b> ECE treatment decreases plaque formation in a dose-dependent manner. …”
-
17
B2 decreases glycolytic intermediates in cells.
Published 2025“…<b>(A)</b> PCA analysis of control, B2 and PFK158 treatment groups. <b>(B)</b> Early glycolytic intermediates and the ratio of F-6-P to F-1,6-BP (<i>lower right</i>) are shown. …”
-
18
-
19
-
20